The incidence of complications and death following gastrectomy for the treatment of gastric cancer has decreased compared to years ago, but still occurs at about 15%. It is believed that the incidence rate can be reduced if the risk factors for complications and death occurring after radical or conventional gastrectomy or conventional bypass surgery are accurately identified. However, the results of studies that specifically analyzed risk factors based on large-scale national survey data are still insufficient. In the case of distant metastasis for gastric cancer patients with a single non-curable factor, it has been reported that conventional gastrectomy surgery after palliative chemotherapy showed no survival benefit in these gastric cancer patients. Therefore, the effect of this conventional gastrectomy cannot be justified.
Studies on factors including the incidence of complications after conventional bypass surgery, conventional gastrectomy, or radical gastrectomy, and risk factors for complications and death are needed. Also, it is essential to clearly confirm the comparison results for factors including risk factors for complications and death after gastrectomy and approaches for gastrectomy.
The current status of complications and deaths after palliative or radical gastrectomy and risk factors including approach methods are analyzed, and complications and deaths are compared for various items that may be included in risk factors.
This Research Topic seeks contributions to different aspects of surgical management for gastric oncology, including postoperative complications and mortality after palliative or curative gastrectomy for gastric cancers.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords:
Gastric Neoplasm; Gastrectomy; Complication; Management; Survival
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
The incidence of complications and death following gastrectomy for the treatment of gastric cancer has decreased compared to years ago, but still occurs at about 15%. It is believed that the incidence rate can be reduced if the risk factors for complications and death occurring after radical or conventional gastrectomy or conventional bypass surgery are accurately identified. However, the results of studies that specifically analyzed risk factors based on large-scale national survey data are still insufficient. In the case of distant metastasis for gastric cancer patients with a single non-curable factor, it has been reported that conventional gastrectomy surgery after palliative chemotherapy showed no survival benefit in these gastric cancer patients. Therefore, the effect of this conventional gastrectomy cannot be justified.
Studies on factors including the incidence of complications after conventional bypass surgery, conventional gastrectomy, or radical gastrectomy, and risk factors for complications and death are needed. Also, it is essential to clearly confirm the comparison results for factors including risk factors for complications and death after gastrectomy and approaches for gastrectomy.
The current status of complications and deaths after palliative or radical gastrectomy and risk factors including approach methods are analyzed, and complications and deaths are compared for various items that may be included in risk factors.
This Research Topic seeks contributions to different aspects of surgical management for gastric oncology, including postoperative complications and mortality after palliative or curative gastrectomy for gastric cancers.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Keywords:
Gastric Neoplasm; Gastrectomy; Complication; Management; Survival
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.